|
Real-time Estimate
Cboe BZX
10:25:15 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 19.46 USD | -0.43% |
|
+4.60% | +7.71% |
| 08-06 | Avalo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-17 | Avalo Therapeutics Says Some Shareholders May Sell Up to 128,189 Shares | MT |
Stock exchange
Quotes 5-day view: Avalo Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-08-07 | 2026-08-10 | 2026-08-11 | 2026-08-12 | 2026-08-13 | |
|---|---|---|---|---|---|
| Last | US$18.32 | US$19.77 | US$19.47 | US$19.55 | US$19.56 |
| Volume | 730,255 | 977,859 | 714,965 | 317,250 | 25,922 |
| Change | -2.03% | +7.91% | -1.52% | +0.41% | -0.43% |
| Opening | US$18.87 | US$18.25 | US$19.67 | US$19.52 | US$19.65 |
| High | US$19.05 | US$20.00 | US$20.01 | US$19.77 | US$19.67 |
| Low | US$17.90 | US$18.00 | US$18.86 | US$19.27 | US$19.33 |
Performance
| 1 day | -0.56% | ||
| 1 week | +4.60% | ||
| Current month | +7.18% | ||
| 1 month | +3.44% | ||
| 3 months | -1.46% | ||
| 6 months | +37.17% | ||
| Current year | +7.71% | ||
| 1 year | +115.54% | ||
| 3 years | -37.31% | ||
| 5 years | -99.76% | ||
| 10 years | -99.83% |
Volumes
marketsDaily volume
25,922
Estimated daily volume
249,928
Avg. Volume 20 sessions
807,309
Daily volume ratio
0.31
Avg. Volume 20 sessions USD
15,714,269.69
Record volume 1
31,910,412
Record volume 2
22,460,588
Record volume 3
8,576,599
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
1,048,466,284
Net sales (USD)
59,000
Number of employees
33
Sales / Employee (USD)
1,788
Free-Float
98.3 %
Free-Float capitalization (USD)
1,030,693,242
Average Daily Capital Traded
1.5%
Indicators
Moving average 5 days
19.16
Moving average 20 days
18.73
Moving average 50 days
17.38
Moving average 100 days
16.56
Price spread / (MMA5)
-1.56%
Price spread / (MMA20)
-3.79%
Price spread / (MMA50)
-10.71%
Price spread / (MMA100)
-14.91%
STIM
RSI 9 days
57.27
RSI 14 days
55.93
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | +4.60% | +115.54% | -37.31% | 1.05B | |
| -0.73% | +7.82% | +73.81% | +102.34% | 70.1B | |
| -0.79% | +0.13% | +37.04% | +65.13% | 54.93B | |
| -2.08% | -2.47% | +5.21% | +479.71% | 28.89B | |
| +0.04% | +10.49% | +48.44% | +7.45% | 23.9B | |
| -0.47% | +1.40% | -18.01% | -13.93% | 23.3B | |
| -1.37% | +7.87% | +251.71% | +464.53% | 18.41B | |
| -0.81% | +7.51% | +40.38% | -20.39% | 18.77B | |
| -0.57% | +3.44% | +25.60% | +619.86% | 16.1B | |
| +0.56% | -3.98% | +30.23% | +133.03% | 12.48B | |
| Average | -0.69% | +7.92% | +61.00% | +180.04% | 26.79B | |
| Weighted average by Cap. | -0.78% | +9.41% | +53.75% | +165.09% |
Historical Quotes: Avalo Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
39973fc86f046b85fef7fe00eecbe75.vlGNtN3uBTNOGPjBwBShSwLfaiqLJQQknGrOwykeLhg.7ibH9rqYNUMGTqK0pGT3L0epOhz9Z0dz_1qfgXlTYX_qI8b5jt9qdAhqkw
| Date | Price | Volume | Total |
|---|---|---|---|
| 10:07:28 | 19.56 | 100 | 19,909 |
| 10:07:27 | 19.55 | 100 | 19,809 |
| 10:07:27 | 19.56 | 100 | 19,709 |
| 10:07:27 | 19.53 | 100 | 19,609 |
| 10:07:27 | 19.51 | 125 | 19,509 |
| 10:05:18 | 19.42 | 351 | 19,384 |
| 10:03:56 | 19.42 | 100 | 19,033 |
| 10:02:19 | 19.43 | 158 | 18,933 |
| 09:59:19 | 19.49 | 100 | 18,775 |
| 09:58:18 | 19.39 | 100 | 18,675 |
Course Extremes
| 1 week | 17.9 |  | 20 |
| 1 month | 17.54 | | 20.01 |
| Current year | 12.51 | | 24.27 |
| 1 year | 8.41 | | 24.27 |
| 3 years | 3.39 | | 71.04 |
| 5 years | 3.39 | | 9,331.13 |
| 10 years | 3.39 | | 22,031.54 |
Monthly variations
Annual variations
| 2026 | +7.65% | ||
| 2025 | +144.41% | ||
| 2024 | -18.35% | ||
| 2023 | -99.25% | ||
| 2022 | -75.29% | ||
| 2021 | -35.61% | ||
| 2020 | -51.02% | ||
| 2019 | +66.87% | ||
| 2018 | +0.94% | ||
| 2017 | +263.47% | ||
| 2016 | -73.72% | ||
| 2015 | -16.25% |
- Stock Market
- Stocks
- AVTX Stock
- Quotes Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
